World's Best Scientists 2026 revealed!
Johannes W. J. Bijlsma

Johannes W. J. Bijlsma

D-Index & Metrics

Medicine

D-Index
121
Citations
69139
World Ranking
3555
National Ranking
135

Johannes W. J. Bijlsma publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Johannes W. J. Bijlsma sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 550 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Johannes W. J. Bijlsma D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Johannes W. J. Bijlsma sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Johannes W. J. Bijlsma is affiliated with Utrecht University in the Netherlands, where they focus their research primarily in the field of Medicine, with a significant concentration on Rheumatology. Their academic work spans several subfields including Surgery, Hematology, Pathology and Forensic Medicine, and Immunology.

The main topics covered by their research include:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Osteoarthritis Treatment and Mechanisms
  • Systemic Lupus Erythematosus Research
  • Lymphoma Diagnosis and Treatment
  • Musculoskeletal Disorders and Rehabilitation
  • Musculoskeletal synovial abnormalities and treatments

Bijlsma has contributed extensively to scientific literature, with a publication record involving prominent journals. Frequent venues for their publications include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • RMD Open
  • Osteoarthritis and Cartilage
  • Arthritis Care & Research

The scientist's recent papers demonstrate involvement in topics related to rheumatoid arthritis and treatment recommendations, including titles such as:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, 2020, Annals of the Rheumatic Diseases
  • Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis, 2020, Annals of the Rheumatic Diseases
  • 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis, 2021, Annals of the Rheumatic Diseases
  • Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis, 2020, Annals of the Rheumatic Diseases
  • EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis, 2021, Annals of the Rheumatic Diseases

Collaboration forms a notable aspect of their work, with frequent co-authors including:

  • Gerd R Burmester (12 joint publications)
  • Maarten Boers (12 joint publications)
  • Tanja Stamm (11 joint publications)
  • Annamaria Iagnocco (10 joint publications)
  • J. Runhaar (10 joint publications)

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • Osteoarthritis: an update with relevance for clinical practice

    Johannes W J Bijlsma;Francis Berenbaum;Floris P J G Lafeber

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

    K M Jordan;N K Arden;M Doherty;B Bannwarth

  • EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis

    Linda Fernandes;Kåre B Hagen;Johannes W J Bijlsma;Oyvor Andreassen

  • EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

    W. Zhang;M. Doherty;B. F. Leeb;L. Alekseeva

  • Effect of collagen turnover on the accumulation of advanced glycation end products.

    Nicole Verzijl;Jeroen DeGroot;Suzanne R. Thorpe;Ruud A. Bank

  • EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis

    W Zhang;M Doherty;G Peat;S Ma Bierma-Zeinstra

  • Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases

    Andrea W. M. Evers;Floris W. Kraaimaat;Wim van Lankveld;Peter J. H. Jongen

  • Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

    L B A van de Putte;C Atkins;M Malaise;J Sany

  • CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.

    Jocea M. R. van Amelsfort;Kim M. G. Jacobs;Johannes W. J. Bijlsma;Floris P. J. G. Lafeber

  • EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

    A Pendleton;N Arden;M Dougados;M Doherty

  • Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: A systematic review of randomized clinical trials

    Margriet E. Van Baar;Willem J. J. Assendelft;Joost Dekker;Rob A. B. Oostendorp

  • Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

    K Visser;W Katchamart;E Loza;J A Martinez-Lopez

  • Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Amalia A van Everdingen;Johannes W G Jacobs;Dirk R Siewertsz Van Reesema;Johannes W J Bijlsma

  • Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis

    T. P. Van Staa;P. Geusens;J. W. J. Bijlsma;H. G. M. Leufkens

  • Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis

    Nicole Verzijl;Jeroen DeGroot;Chaya Ben Zaken;Orit Braun-Benjamin

  • Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

    J A P Da Silva;J W G Jacobs;J R Kirwan;M Boers

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

Frequent Co-Authors

Floris P. J. G. Lafeber
Floris P. J. G. Lafeber Utrecht University
Rinie Geenen
Rinie Geenen Utrecht University
Joel A G van Roon
Joel A G van Roon University Medical Center Utrecht
Joost Dekker
Joost Dekker University of Amsterdam
Maurizio Cutolo
Maurizio Cutolo University of Genoa
Frank Buttgereit
Frank Buttgereit Charité - University Medicine Berlin
Floris W. Kraaimaat
Floris W. Kraaimaat Radboud University
Gerd R. Burmester
Gerd R. Burmester Charité - University Medicine Berlin
Maxime Dougados
Maxime Dougados Hôpital Cochin
Sita M. A. Bierma-Zeinstra
Sita M. A. Bierma-Zeinstra Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens many doors, not only for aspiring doctors but also for those interested in the broader healthcare sector. If you’re exploring alternative or related career paths, online nursing degrees provide flexible and often more affordable opportunities.

For those aiming for advanced roles in research or academic settings, an online phd in nursing can be an excellent next step. Meanwhile, registered nurses looking to strengthen their credentials and increase their earning potential may find the cheapest rn to bsn programs are both accessible and budget-friendly.

Even individuals without a nursing background can swiftly enter the nursing field thanks to direct entry msn programs for non nurses online. These accelerated degrees are designed to build new skills quickly. And if you’re concerned about competitiveness, several nursing schools with high acceptance rates offer easier admissions, making it easier to launch your healthcare career.

Best Scientists Citing Johannes W. J. Bijlsma

Trending Scientists

Recently Published Articles